Something about BiDil has really stirred the pot, prompting fierce debate about whether race is a meaningful or useful term from a medical point of view.
********* UNDERSET 7 LINES *********
“I think we have to get away from feeling uncomfortableness in asking people’s ethnicity.”
Dr Alex Brown
********* UNDERSET 22 LINES *********
HEART failure drug BiDil burst onto the pharmaceutical scene last year amid the sort of public debate usually reserved for erectile dysfunction treatments. The isosorbide dinitrate and hydralazine hydrochloride combination had been left for dead a decade earlier, after trials in a mixed population achieved poor results. But when a retrospective analysis revealed the drug had surprisingly high efficacy among African-Americans, US pharmaceutical company NitroMed launched a trial in that population. The...
The content on this site is available to Australian Registered Health Practitioners only. Please login or register for access.